Overview

Determination of the Lowest, Safe and Effective Dose of Proellex

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of five different doses of Proellex on menses, ovulation, liver function, and steady state exposure in women of reproductive age.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Repros Therapeutics Inc.